Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch from pregabalin to mirogabalin for peripheral neuropathic pain
jRCTs031190113Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mirogabalin in Peripheral neuropathic pain, sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Occurrence of somnolence, dizziness, and peripheral edema. Started Oct 2019; status: completed.
02
Drugs
mirogabalin
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on jRCTs031190113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031190113.